Tau protein aggregates are a common pathological feature of Alzheimer's disease and numerous rare neurodegenerative diseases, such as progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD), collectively called tauopathies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.